Her2-positive breast cancer - Globe Thesis

Keyword [Her2-positive breast cancer] Result: 41 - 59 \| Page: 3 of 3
41.	Design,Expression,functional Verification And Molecular Dynamics Analysis Of Cell-penetrating Peptide Conjugated Antibody
42.	Ginsenoside Rh1 Inhibits The Malignant Biological Behavior Of HER2-positive Breast Cancer Cells Through DDX5
43.	Metabolomic analysis of her2-positive breast cancer cells
44.	Analysis of the oncogenic cooperation between mutp53 and HER2 to propose mutp53 as a biomarker for HER2-positive breast cancer
45.	The Application Study Of Liquid Biopsy In The Individualized Therapy Of HER2 Positive Breast Cancer Patients
46.	The Exploratory Study Of Trastuzumab Resistant Mechanism In Human Epidermal Growth Factor Receptor 2 Positive Breast Cancer Using Circulating Tumor Cells
47.	Influence Of YAP On Resistance Of HER2-Positive Breast Cancer Cells To Trastuzumab And Related Mechanisms
48.	The Relationship Between The Androgen Receptor And EBP1 In HER2-positive Breast Cancer
49.	A Study Of Risk Assessment For Recurrence Of HER2-Positive Breast Cancer And Changes In Tumor Immune Microenvironment During The Course Of Targeted Therapy
50.	Significance Of KIF3B Expression In HER2 Positive Breast Cancer And Its Correlation With Epithelial-mesenchymal Transformation
51.	Analysis Of Updated Guidelines For Detection Of HER2 In Breast Cancer And Study Of Pathological Characteristics Of HER2 Positive Breast Cancer
52.	Prognostic Analysis Of 311 Patients With Early HER2-Positive Breast Cancer
53.	Prognostic Implications Of The Pathological Prognostic Staging System Of The AJCC 8th Edition For Patients With HER2-positive Breast Cancer
54.	Meta-analysis Of The Efficacy And Safety Of Neoadjuvant Trastuzumab Combined With Pertuzumab For HER2-positive Breast Cancer
55.	Observational Study Of Adjuvant And Neoadjuvant Dual-target Therapy For HER2 Positive Breast Cancer
56.	Predictive Value Of HER2 Protein Expression Level In Pat Ients With HER2-positive Breast Cancer Receiving Neoadj Uvant Therapy
57.	M6A Demethylase FTO Promotes The Resistance Of HER2-positive Breast Cancer Cell To Trastuzumab
58.	Study On The Expression Of Related Molecules In The Process Of Drug Resistance And Reversal Of Trastuzumab In HER2 Positive Breast Cancer Cells
59.	Research On The Mechanism Of Taxol Resistance Of The HER2-positive Breast Cancer Cell Line SKBR-3
<<First <Prev Next> Last>> Jump to